Exelixis Inc (NASDAQ:EXEL) - Share price - Overview


Stock Report

Exelixis Inc EXEL

Last Price
$20.90

Day Change
-0.46|-2.15%

As of 18/04/2019
17:52:59 EDT | USD
Minimum 15 Minutes Delay.

Last Close21.36
Day Range20.31 - 21.56
Mkt Cap6.30Bil
52-Wk Range13.42 - 25.31
Yield %-
ISINUS30161Q1040
Volume4,162,462
P/E9.46
P/S7.66
P/CF15.73

Share Price

Financials
201620172018
More ...
Income Statement
Revenue191.45452.48853.83
Operating Income-27.21165.88438.86
Net Income-70.22154.23690.07
Basic EPS-0.280.522.32
Avg. Diluted Shares Outstanding251312313
Balance Sheet
Current Assets470.80484.87897.02
Non Current Assets126.74170.42525.27
Total Assets597.54655.291,422.29
Current Liabilities270.59115.17105.47
Total Liabilities508.22370.33134.83
Total Equity89.32284.961,287.45
Cash Flow
Operating Cash Flow206.30165.61415.72
Capital Expenditure-1.70-21.14-33.30
Free Cash Flow204.59144.47382.42

In millions, except "Basic EPS". Currency is USD.

Company Profile

Exelixis Inc is a biotechnology company. It is involved in discovery, development, and commercialization of new medicines for people with cancer. The Cabometyx product generates maximum revenue for the company.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Mid-Growth

Fiscal Year Ends

December

Employees

484
Key Stats
More ...
Price/Earning TTM9.21
Price/Book5.00
Price/Sales TTM7.83
Rev Growth (3 year avg)184.26
EPS Growth (3 year avg)-
Operating Margin % TTM51.40
Net Margin % TTM80.82
ROE TTM87.77
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.